BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21887912)

  • 41. IgA nephropathy associated with hepatitis C virus infection.
    Gonzalo A; Navarro J; Bárcena R; Quereda C; Ortuño J
    Nephron; 1995; 69(3):354. PubMed ID: 7753282
    [No Abstract]   [Full Text] [Related]  

  • 42. Parotid gland oncocytoma in HCV-positive patient with non-Hodgkin's lymphoma. Case report.
    Fini G; Cascino F; Moricca LM; Scannavivo CM; Mici E; Merola R; Malavenda MS; Krizzuk D; Maturo A; Pasta V
    G Chir; 2013; 34(1-2):18-20. PubMed ID: 23463927
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Successful interferon-α treatment in a patient with IgA nephropathy associated with hepatitis C virus infection.
    Ji F; Li Z; Ge H; Deng H
    Intern Med; 2010; 49(22):2531-2. PubMed ID: 21088367
    [No Abstract]   [Full Text] [Related]  

  • 44. Hepatitis C virus infection and non-Hodgkin lymphoma: interesting association or causal relationship?
    Anderson LA; Engels EA
    Int J Cancer; 2008 Apr; 122(8):x-xii. PubMed ID: 18271007
    [No Abstract]   [Full Text] [Related]  

  • 45. Hepatitis C virus infection and lymphomas.
    Paydas S
    Int J Cancer; 2005 Jan; 113(2):338. PubMed ID: 15386415
    [No Abstract]   [Full Text] [Related]  

  • 46. B cell malignancy and hepatitis C virus infection.
    Izumi T; Sasaki R; Miura Y; Okamoto H
    Leuk Res; 1996 May; 20(5):445. PubMed ID: 8683985
    [No Abstract]   [Full Text] [Related]  

  • 47. Favorable outcome of IgA nephropathy on antituberculous treatment.
    Mercadal L; Hulot JS; Isnard-Bagnis C; Baumelou A; Beaufils H; Deray G
    Minerva Urol Nefrol; 2006 Dec; 58(4):355-7. PubMed ID: 17268402
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is hepatitis C associated with non-Hodgkin's lymphoma?
    Singer IO; Cumming RL; Hogg RB
    Leuk Lymphoma; 1997 Aug; 26(5-6):633-4. PubMed ID: 9389373
    [No Abstract]   [Full Text] [Related]  

  • 49. IgA-dominant glomerulonephritis associated with hepatitis A.
    Cheema SR; Arif F; Charney D; Meisels IS
    Clin Nephrol; 2004 Aug; 62(2):138-43. PubMed ID: 15356971
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Paraneoplastic cutaneous vasculitis revealing non-Hodgkin's lymphoma].
    Chebbi W; Zantour B
    Pan Afr Med J; 2014; 17():134. PubMed ID: 25374639
    [No Abstract]   [Full Text] [Related]  

  • 51. Are blood donors an adequate control group to ascertain HCV prevalence in non-Hodgkin's lymphoma patients.
    Iannitto E; De Cantis S; Cirrincione S; Ammatuna E; Di Trapani R; Quintini G; Carroccio A; Mariani G
    J Gastroenterol Hepatol; 2002 Sep; 17(9):1039-40. PubMed ID: 12167130
    [No Abstract]   [Full Text] [Related]  

  • 52. HCV and lymphomagenesis.
    Galli M; Pioltelli P; Zehender G; Monti G; Monteverde A
    Lancet; 1996 Jul; 348(9022):275. PubMed ID: 8684233
    [No Abstract]   [Full Text] [Related]  

  • 53. Prevalence of HCV infection and second neoplasms in marginal zone lymphomas.
    Luppi M; Longo G; Ferrari MG; Ferrara L; Marasca R; Barozzi P; Morselli M; Emilia G; Torelli G
    Br J Haematol; 1997 Mar; 96(4):873-4. PubMed ID: 9074436
    [No Abstract]   [Full Text] [Related]  

  • 54. Non-Hodgkin's lymphoma: possible role of hepatitis C virus.
    Ferri C; La Civita L; Caracciolo F; Zignego AL
    JAMA; 1994 Aug; 272(5):355-6. PubMed ID: 8028163
    [No Abstract]   [Full Text] [Related]  

  • 55. Development of non-Hodgkin lymphoma as a second primary cancer in hepatitis C virus-infected patients with a different primary malignancy.
    Economides MP; Mahale P; Turturro F; Hosry J; Samaniego F; Granwehr BP; Torres HA
    Leuk Lymphoma; 2017 Feb; 58(2):485-488. PubMed ID: 27348218
    [No Abstract]   [Full Text] [Related]  

  • 56. HCV and non-Hodgkin lymphoma.
    Hanley J; Jarvis L; Simmonds P; Parker A; Ludlam C
    Lancet; 1996 May; 347(9011):1339. PubMed ID: 8622540
    [No Abstract]   [Full Text] [Related]  

  • 57. [An autopsied case of primary hepatic malignant lymphoma associated with chronic active hepatitis C].
    Kizawa K; Tsuneyama K; Terada T; Nakanuma Y; Miwa U; Kurumaya H
    Nihon Shokakibyo Gakkai Zasshi; 1993 Sep; 90(9):2147-51. PubMed ID: 8411754
    [No Abstract]   [Full Text] [Related]  

  • 58. Subretinal drusenoid deposits associated with complement-mediated IgA nephropathy.
    Lally DR; Baumal C
    JAMA Ophthalmol; 2014 Jun; 132(6):775-7. PubMed ID: 24921170
    [No Abstract]   [Full Text] [Related]  

  • 59. [Hepatitis C virus infection in patients with non Hodgkin's lymphoma].
    Domingo JM; Romero MS; Palomera L; Gutiérrez M
    Med Clin (Barc); 2001 Nov; 117(16):638. PubMed ID: 11714475
    [No Abstract]   [Full Text] [Related]  

  • 60. Lymphoma and human immunodeficiency virus (HIV) infection: another favourable setting?
    Torresin A; Feasi M; Cassola G
    Ann Oncol; 2007 Aug; 18(8):1422-3. PubMed ID: 17693657
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.